118 related articles for article (PubMed ID: 38902550)
1. Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease.
Yin H; Fan Y; Yu J; Xiong B; Zhou B; Sun Y; Wang L; Zhu Y; Xu H
Insights Imaging; 2024 Jun; 15(1):159. PubMed ID: 38902550
[TBL] [Abstract][Full Text] [Related]
2. Two-dimensional Convolutional Neural Network Using Quantitative US for Noninvasive Assessment of Hepatic Steatosis in NAFLD.
Jeon SK; Lee JM; Joo I; Yoon JH; Lee G
Radiology; 2023 Apr; 307(1):e221510. PubMed ID: 36594835
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Study of Ultrasound Attenuation Imaging, Controlled Attenuation Parameters, and Magnetic Resonance Spectroscopy for the Detection of Hepatic Steatosis.
Bao J; Lv Y; Wang K; Wang Q; Chen Y; Dong Y; Zhu Y; Wang W
J Ultrasound Med; 2023 Jul; 42(7):1481-1489. PubMed ID: 36583414
[TBL] [Abstract][Full Text] [Related]
4. Head-to-head comparison of three different US-based quantitative parameters for hepatic steatosis assessment: a prospective study.
Zhou Y; Nie M; Zhou H; Mao F; Zhao L; Ding J; Jing X
Abdom Radiol (NY); 2024 May; ():. PubMed ID: 38740581
[TBL] [Abstract][Full Text] [Related]
5. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
Runge JH; Smits LP; Verheij J; Depla A; Kuiken SD; Baak BC; Nederveen AJ; Beuers U; Stoker J
Radiology; 2018 Feb; 286(2):547-556. PubMed ID: 28915103
[TBL] [Abstract][Full Text] [Related]
6. A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD.
Zhu Y; Yin H; Zhou D; Zhao Q; Wang K; Fan Y; Chen K; Han H; Xu H
Abdom Radiol (NY); 2024 Jan; 49(1):81-92. PubMed ID: 37950767
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy.
Karlas T; Petroff D; Garnov N; Böhm S; Tenckhoff H; Wittekind C; Wiese M; Schiefke I; Linder N; Schaudinn A; Busse H; Kahn T; Mössner J; Berg T; Tröltzsch M; Keim V; Wiegand J
PLoS One; 2014; 9(3):e91987. PubMed ID: 24637477
[TBL] [Abstract][Full Text] [Related]
8. Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults.
Price JC; Dodge JL; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski S; Tien PC
AIDS; 2017 Sep; 31(15):2119-2125. PubMed ID: 28723710
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity.
Runge JH; van Giessen J; Draijer LG; Deurloo EE; Smets AMJB; Benninga MA; Koot BGP; Stoker J
Eur Radiol; 2021 Mar; 31(3):1588-1596. PubMed ID: 32910234
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population.
Kuchay MS; Choudhary NS; Sharma D; Krishan S; Mishra SK; Wasir JS; Singh MK; Saraf N; Dhampalwar S; Sud R
J Clin Exp Hepatol; 2022; 12(3):893-898. PubMed ID: 35677514
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of multivariable quantitative ultrasound for diagnosing hepatic steatosis.
Jeon SK; Lee JM; Cho SJ; Byun YH; Jee JH; Kang M
Sci Rep; 2023 Sep; 13(1):15235. PubMed ID: 37709827
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of magnetic resonance imaging proton density fat fraction (MRI-PDFF), magnetic resonance spectroscopy (MRS), and two different histopathologic methods (artificial intelligence
Kim JW; Lee CH; Yang Z; Kim BH; Lee YS; Kim KA
Quant Imaging Med Surg; 2022 Nov; 12(11):5251-5262. PubMed ID: 36330193
[TBL] [Abstract][Full Text] [Related]
13. Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease.
Jeon SK; Lee JM
Insights Imaging; 2024 Feb; 15(1):46. PubMed ID: 38353856
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound and FibroScan
Salmi A; di Filippo L; Ferrari C; Frara S; Giustina A
Endocrine; 2022 Nov; 78(2):262-269. PubMed ID: 35980569
[TBL] [Abstract][Full Text] [Related]
15. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
Chan WK; Nik Mustapha NR; Mahadeva S
J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
[TBL] [Abstract][Full Text] [Related]
16. Assessment of transient elastography in diagnosing MAFLD and the early effects of sleeve gastrectomy on MAFLD among the Chinese population.
Hu R; Wu B; Wang C; Wu Z; Zhang X; Chen X; Lu G; Yuan K
Int J Surg; 2024 Apr; 110(4):2044-2054. PubMed ID: 38215263
[TBL] [Abstract][Full Text] [Related]
17. Correlation and Performance of three Ultrasound Techniques to Stage Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
Shen Q; Hao Y; Chen J; Liu Q; Jia H; Liu L
Curr Med Imaging; 2024; 20():1-12. PubMed ID: 38389362
[TBL] [Abstract][Full Text] [Related]
18. Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease.
Shao CX; Ye J; Dong Z; Li F; Lin Y; Liao B; Feng S; Zhong B
Ther Adv Chronic Dis; 2021; 12():20406223211033119. PubMed ID: 34408822
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosis.
Georgoff P; Thomasson D; Louie A; Fleischman E; Dutcher L; Mani H; Kottilil S; Morse C; Dodd L; Kleiner D; Hadigan C
AJR Am J Roentgenol; 2012 Jul; 199(1):2-7. PubMed ID: 22733887
[TBL] [Abstract][Full Text] [Related]
20. Potential of electron beam computed tomography for coronary artery calcium screening to evaluate fatty liver: comparison with 1H magnetic resonance spectroscopy in the Dallas Heart Study.
Matulevicius S; Huff LC; Szczepaniak LS; Ayers CR; Budoff M; McColl R; Khera A; Peshock RM
J Investig Med; 2011 Jun; 59(5):780-6. PubMed ID: 21441828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
